Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
5.19
-0.02 (-0.38%)
Aug 26, 2026, 12:30 PM EDT - Market open

Oramed Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
174.8764.05-19.065.53-36.56-35
Depreciation & Amortization
0.120.120.190.20.060.05
Loss (Gain) From Sale of Assets
-----0.01-
Loss (Gain) From Sale of Investments
-223.13-86.17.41-16.390.760.22
Stock-Based Compensation
6.135.994.054.2211.535.33
Other Operating Activities
26.830.78-4.21-1.15-2.75-1.86
Change in Accounts Payable
5.441.133.53-2.23-0.382.07
Change in Unearned Revenue
-3.02-2.11--1.34-0.7-2.71
Change in Other Net Operating Assets
-0.36-0.93-0.330.870.14-1.45
Operating Cash Flow
-5.21-9.15-8.41-10.3-27.92-33.37
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.01-0.01-0.02-0.25-0.5-0.03
Sale of Property, Plant & Equipment
----0.02-
Sale (Purchase) of Real Estate
0.03-1.92----
Investment in Securities
21.6811.13105.9-72.7830.69-297.72
Other Investing Activities
2.81-0.75-0.07--0-
Investing Cash Flow
21.55.44105.82-73.0430.21-297.74

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---99.55--
Total Debt Issued
---99.55--
Short-Term Debt Repaid
---49.55-50--
Total Debt Repaid
---49.55-50--
Net Debt Issued (Repaid)
---49.5549.55--
Issuance of Common Stock
---2.4311.56181.72
Repurchase of Common Stock
-6.24-4.74-2.49--0.78-
Financing Cash Flow
-16.68-4.74-52.0451.9810.78181.72

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.17-0.03-0-0.05-0.060.03
Net Cash Flow
-0.55-8.4745.37-31.4113.01-149.37

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-5.22-9.15-8.43-10.55-28.41-33.39
Free Cash Flow Growth
------
Free Cash Flow Margin
--457.70%--787.24%-1051.20%-1231.31%
Free Cash Flow Per Share
-0.12-0.22-0.21-0.26-0.73-0.90
Levered Free Cash Flow
2.513.92-1.51-9.68-15.75-
Unlevered Free Cash Flow
2.513.92-0.98-8.41-15.75-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
--2.320.57--
Cash Income Tax Paid
----0.10.3
Change in Working Capital
9.9863.2-2.7-0.94-2.1
SEC Filings: 10-K · 10-Q